Peter P. Wibroe

Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes

Peter P. Wibroe, Aaron C. Anselmo, Per H. Nilsson et al. · Nature Nanotechnology · 2017 · 194 citations · Full text

Nanoparticles, Nanomedicine, Engineering +7

An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome

Peter P. Wibroe, Davoud Ahmadvand, Mohammad Ali Oghabian et al. · Journal of Controlled Release · 2015 · 186 citations

Lipid Preparation, Drug Targeting, Integrated Assessment +3

A structurally diverse library of safe-by-design citrem-phospholipid lamellar and non-lamellar liquid crystalline nano-assemblies

Intan Diana Mat Azmi, Peter P. Wibroe, Linping Wu et al. · Journal of Controlled Release · 2016 · 96 citations

Lipid Preparation, Engineering, Self-assembly +7

Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: Towards development of safe tunable intravenous lipid nanocarriers

Peter P. Wibroe, Intan Diana Mat Azmi, Christa Nilsson et al. · Nanomedicine Nanotechnology Biology and Medicine · 2015 · 75 citations

Lipid Preparation, Nanomedicine, Engineering +8

Modulatory Effect of Human Plasma on the Internal Nanostructure and Size Characteristics of Liquid-Crystalline Nanocarriers

Intan Diana Mat Azmi, Linping Wu, Peter P. Wibroe et al. · Langmuir · 2015 · 70 citations

Nanoparticles, Engineering, Colloidal Nanocrystals +17